Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human cIAP-1/HIAP-2 Antibody, R&D Systems™

Mouse Monoclonal Antibody
Supplier: R&D Systems MAB8181
This item is not returnable.
View return policy
Description
cIAP-1/HIAP-2 Monoclonal specifically detects cIAP-1/HIAP-2 in Human samples. It is validated for Immunohistochemistry.Specifications
| cIAP-1/HIAP-2 | |
| Monoclonal | |
| LYOPH | |
| Immunohistochemistry 8-25 ug/mL | |
| Q13490 | |
| BIRC2 | |
| E. coli-derived recombinant human cIAP-1/HIAP-2 His2-Ser618 Accession # Q13490 | |
| 100 μg | |
| Primary | |
| Detects human cIAP-1/HIAP-2 in direct ELISAs. In direct ELISAs, 25% cross-reactivity with recombinant human cIAP-2 is observed. | |
| Human | |
| Purified |
| Immunohistochemistry | |
| 681724 | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| API1Hiap-2, apoptosis inhibitor 1, baculoviral IAP repeat containing 2, baculoviral IAP repeat-containing 2, baculoviral IAP repeat-containing protein 2, BIRC2, cIAP1, C-IAP1, hIAP2, HIAP-2, IAP homolog B, IAP2, IAP-2, Inhibitor of apoptosis protein 2, MIHB, MIHBHIAP2, NFR2-TRAF signalling complex protein, RING finger protein 48, RNF48hiap-2, TNFR2-TRAF-signaling complex protein 2 | |
| Mouse | |
| Protein A or G purified from hybridoma culture supernatant | |
| RUO | |
| 329 | |
| Sterile PBS to a final concentration of 0.5 mg/mL. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
| IgG1 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction